Bioorganic & Medicinal Chemistry Letters 2007-07-01

Design, synthesis, and anti-HIV activity of 2',3'-didehydro-2',3'-dideoxyuridine (d4U), 2',3'-dideoxyuridine (ddU) phosphoramidate 'ProTide' derivatives.

Youcef Mehellou, Christopher McGuigan, Andrea Brancale, Jan Balzarini

Index: Bioorg. Med. Chem. Lett. 17(13) , 3666-9, (2007)

Full Text: HTML

Abstract

We report the synthesis of 2',3'-didehydro-2',3'-dideoxyuridine (d4U) and 2',3'-dideoxyuridine (ddU) phosphoramidate 'ProTide' derivatives and their evaluation against HIV-1 and HIV-2. In addition, we conducted molecular modeling studies on both d4U and ddU monophosphates to investigate their second phosphorylation process. The findings from the modeling studies provide compelling evidence for the lack of anti-HIV activity of d4U phosphoramidates, in contrast with the corresponding ddU phosphoramidates.

Related Compounds

Related Articles:

Abacavir and metabolite pharmacokinetics in HIV-1-infected children and adolescents.

2009-05-01

[J. Acquir. Immune Defic. Syndr. 51(1) , 54-9, (2009)]

Potent DNA chain termination activity and selective inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxyuridine-5'-triphosphate.

1990-02-01

[Mol. Pharmacol. 37(2) , 157-63, (1990)]

Glycosyl-oxycarbonylaminosulfonyl-2',3'-dideoxynucleoside derivatives as lipophilic nucleotide mimics. Synthesis and anti-HIV activity.

1993-10-01

[Bioorg. Med. Chem. 1(4) , 279-84, (1993)]

Synthesis and in vitro antiviral activities of 3'-fluoro (or chloro) and 2',3'-difluoro 2',3'-dideoxynucleoside analogs against hepatitis B and C viruses.

2010-11-01

[Bioorg. Med. Chem. 18(21) , 7542-7, (2010)]

Production of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine from 2',3'-dideoxyuridine and the corresponding purine bases by resting cells of Escherichia coli AJ 2595.

1989-02-01

[Appl. Environ. Microbiol. 55(2) , 419-24, (1989)]

More Articles...